Literature DB >> 844036

Characterization of a new continuous cell line derived from a human retinoblastoma.

R C McFall, T W Sery, M Makadon.   

Abstract

A new continuous cell line derived from a human retinoblastoma has been established. This cell line, WERI-RB1, has been maintained in vitro since December 1974. The purpose of this investigation was to characterize WERI-Rb1 on the basis of morphology, growth, tumorigenicity, cytogenetics, and to compare this cell line with Y79, a human retinoblastoma cell line established at another institution. Morphologically, both cell lines were similar; each spontaneously grew as a suspension of small round cells in grapelike clusters. Each exhibited growth of cells in rosettes, as well as unusual chain formations. Growth rates differed: the population-doubling times for WERI-Rb1 and Y79 were 96 and 33 hr, respectively. When the negative surface charge on a plastic tissue culture flask was changed, each cell line grew as a monolayer. Y79 could be cloned in soft agar; WERI-Rb1 could not. An inoculm of 10(7) WERI-Rb1 or Y79 cells produced a retinoblastoma in test rabbits. Karyological examination showed each cell line to have a stable, near diploid chromosome number. Although large markers were observed in each line, they shared no common marker.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 844036

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  76 in total

1.  Metastatic and nonmetastatic models of retinoblastoma.

Authors:  P Chévez-Barrios; M Y Hurwitz; K Louie; K T Marcus; V N Holcombe; P Schafer; C E Aguilar-Cordova; R L Hurwitz
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  DNA-binding properties of the E1A-associated 300-kilodalton protein.

Authors:  Y Rikitake; E Moran
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  A conditional immortalized mouse muller glial cell line expressing glial and retinal stem cell genes.

Authors:  Deborah C Otteson; M Joseph Phillips
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

4.  Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

Authors:  R Bremner; D C Du; M J Connolly-Wilson; P Bridge; K F Ahmad; H Mostachfi; D Rushlow; J M Dunn; B L Gallie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  Effects of matrine on proliferation and apoptosis of cultured retinoblastoma cells.

Authors:  Bowen Zhao; Bin Li; Shuwei Bai; Ling Shen; Ruojin Ren; Jost B Jonas; Xiaolin Xu; Qingjun Lu; Qian Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-25       Impact factor: 3.117

6.  Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest.

Authors:  G S Dbaibo; M Y Pushkareva; S Jayadev; J K Schwarz; J M Horowitz; L M Obeid; Y A Hannun
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Retinoblastoma Y79 cell line: a study of membrane structures.

Authors:  A L Green; E S Meek; D W White; R H Stevens; L D Ackerman; G F Judisch; S R Patil
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-10

8.  Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells.

Authors:  Viral Kansara; Durga Paturi; Shuanghui Luo; Ripal Gaudana; Ashim K Mitra
Journal:  Int J Pharm       Date:  2007-12-23       Impact factor: 5.875

9.  Changes in retinoblastoma cell adhesion associated with optic nerve invasion.

Authors:  Nikia Laurie; Adithi Mohan; Justina McEvoy; Damon Reed; Jiakun Zhang; Brett Schweers; Itsuki Ajioka; Virginia Valentine; Dianna Johnson; David Ellison; Michael A Dyer
Journal:  Mol Cell Biol       Date:  2009-09-28       Impact factor: 4.272

10.  Cotylenin A inhibits cell proliferation and induces apoptosis and PAX6 mRNA transcripts in retinoblastoma cell lines.

Authors:  Yoshiko Kashiwagi; Nobuo Kato; Takeshi Sassa; Koichi Nishitsuka; Teiko Yamamoto; Hiroshi Takamura; Hidetoshi Yamashita
Journal:  Mol Vis       Date:  2010-06-04       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.